Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 3Recruiting 2Active not recruiting 2Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 4Tumor-Agnostic 3Lymphoid 3Breast 3Plasma cell 2Head & Neck 2Gynecologic 2Thoracic 1Gastrointestinal 1

Conditions

Lymphoma 3Neoplasms, Plasma Cell 1

Interventions

Rituximab 702Cyclophosphamide 645Vincristine 353Doxorubicin 309Etoposide 305Cytarabine 271Filgrastim 250Prednisone 249Methotrexate 241fludarabine phosphate 231Dexamethasone 209fludarabine 184Peripheral Blood Stem Cell Transplantation 166Radiotherapy 161Granulocyte Colony-Stimulating Factor 145Lenalidomide 144Bendamustine Hydrochloride 142Bortezomib 127Melphalan 126ibrutinib 111Busulfan 111Mycophenolic Acid 108Whole-Body Irradiation 107Tacrolimus 96Cyclosporine 87Gemcitabine 82Ifosfamide 80Calcium Dobesilate 80Alemtuzumab 80Leucovorin 78

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Geriatric Assessment × Lymphoid × Clear all
NCT05101759 2024-09-25

LYMPHOLD

University Hospital, Toulouse

Phase NA Completed
100 enrolled
LymphoidPlasma cell

Lymphoma, Neoplasms, Plasma Cell

NCT02054741 2024-04-12

Geriatric Assessment Intervention for Reducing Toxicity in Older Patients With Advanced Cancer

University of Rochester

Phase NA Completed
733 enrolled 27 charts
Lymphoid

Lymphoma

NCT02107443 2024-04-12

COACH

University of Rochester

Phase NA Completed
546 enrolled 15 charts
Lymphoid

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡